Cefbuperazone was compared with other currently available and investigational antibiotics against 278 clinical isolates of anaerobic gram-negative bacilli by an agar dilution method. Cefbuperazone and cefotetan were equally active against Bacteroides fragiis, with 8% of the organisms tested found to be resistant to 32 ,ug of either drug per ml, Cefoperazone, cefotaxime, ceftriaxone, and cefmetazole were less active against these strains; cefoxitin, moxalactam, piperacillin, clindamycin, and metronidazole were more active. None of the agents were consistently active against any of the other anaerobic gram-negative bacilli except imipenem, for which the minimum concentration required to inhibit 90% of all strains tested was 4 ,ug/ml. A 10,000-fold increase in inoculum size caused an increase in the MIC of ceftriaxone, cefotaxime, and cefoperazone bUt not of-cefbuperazone, cefotetan, or cefoxitin. Investigation of the mechanism of resistance to cephalosporin-like agents demonstrated a correlation between the level of resistance and Il-lactamase activity. Cefbuperazone, cefotetan, and cefoxitin were not hydrolyzed, had lower MICs, and were less affected by changes in inoculum size than were cefotaxime, ceftriaxone, and cefoperazone.
This study was undertaken to evaluate the activity of cefbuperazone, several new penicillins and cephalosporins, moxalactam, and imipenem against clinically important, frequently occurring anaerobic gram-negative bacilli and compare them with currently available agents which have useful activity against anaerobic bacteria. Anaerobic gramnegative bacilli were chosen for the evaluation for the following reasons: (i) these organisms are the major pathogenic anaerobes isolated in the clinical laboratories of the Medical University of South Carolina teaching hospitals; (ii) antimicrobial susceptibility of these organisms is not frequently tested in routine hospital laboratories; and (iii) there is great confusion as to which antimicrobial agents are most effective against these organisms in vitro. MIC, inoculum size effects, stability of the compounds to Bacteroides fragilis ,B-lactamase, and contribution of ,-lactamase to resistance were also investigated.
MATERIALS AND METHODS
Antibiotics. Antibiotics and their respective suppliers were as follows: cefbuperazone and cefmetazole, Bristol Laboratories, Syracuse, N.Y.; cefoperazone, Pfizer Inc., New (6) . One hundred and fiftyfive strains were B. fragilis, previously B. fragilis subsp. fragilis. The other organisms of the B. fragilis group studied included 27 strains of B. ovatus-thetaiotaomicron and 35 strains of other identifiable species of the B. fragilis group. Thirty-one strains of Bacteroides species which did not fit into any particular designation were also studied. Fifteen strains of B. melaninogenicus and 15 strains of Fusobacterium species were also studied. Organisms were stored at -70°C on glass beads coated with 1% brain heart infusion agar. B. fragilis ATCC 25285 and B. thetaiotaomicron ATCC 29741 were used throughout the study as control organisms.
Susceptibility studies. MICs for the organisms tested were determined by the agar dilution method described by Sutter et al. (14) . Overnight cultures of test organisms were diluted to the optical density of a 0.5 McFarland standard. These suspensions were inoculated with a Steers-Foltz replicator onto brain heart infusion agar supplemented with cysteine, hemin, and menadione and containing serial twofold dilutions of test antibiotics (13) . Results were determined after 48 h of incubation at 37°C in an anaerobic glove box. The MIC was defined as the lowest concentration of antibiotic at which there was no growth, one discrete colony, or a fine, barely visible haze as determined with the unaided eye. Comparative studies were performed in triplicate for each batch of organisms. The American Type Culture Collection control strains were included with each group. P-Lactamase studies. Eight strains of B. fragilis were studied for their ,-lactamase activity by a method described elsewhere (2, 5) . Small volumes of overnight culture were added to larger volumes of warm, prereduced broth. The cells were harvested in the logarithmic phase of growth after 6 h of incubation. After centrifugation and suspension in b Breakpoint refers to regularly achievable serum levels after the administration of moderate or (in parentheses) high dosage. phosphate buffer at 1/100 of the original volume, the cells and clindamycin and metronidazole were more active than were disrupted by intermittent sonication for a total of 3 min any of the currently available P-lactaml agents. The resisat 100 W and centrifuged to remove cellular debris. The tance rates of all other anaerobic gram-negative bacilli protein concentration was determined spectrophotometstudied are shown at the low and high breakpoint concenrically by the Biuret method. Quantitative assessment of trations in Table 2 . No organisms were resistant to imipe-P-lactamase activity of the enzyme preparation was per-nem. specific substrate antibiotic is shown in Table 3 . In general, among the cephalosporins there was a correlation betweenthe degree of resistance and the amount of hydrolysis for each strain, which was especially striking for cephaloridine, cefoperazone, and ceftriaxone. Decreasing levels of resistance of these strains to the cephalosporins were accompanied by less 1-lactamase activity. Cefbuperazone, cefoxitin, and cefotetan were resistant to B. fragilis f-lactam,ase. No hydrolysis of penicillin, ticarcillin, piperacillin, or moxalactam was observed.
Studies of the stability of the various cephalosporin agents to B. fragilis P-lactamase showed cephaloridine to be the most rapidly hydrolyzed. With the rate of hydrolysis of cephaloridine arbitrarily set at 100%, a relative rate of hydrolysis for the other P-lactam agents was calculated (Table 4) . Among the hydrolyzable agents, cefotaxime, cefoperazone, and ceftriaxone showed decreasing amounts of hydrolysis, whereas cefbuperazone, cefoxitin, and cefotetan were not hydrolyzed.
The effect on MIC of increasing the inoculum of eight selected strains of B. fragilis (those on which hydrolysis activity is reported here) from 5 x 102 to 5 x 106 organisms is seen in Table 4 . The result is expressed as the average increase in twofold dilutions for each cephalosporin tested. The most pronounced inoculum effects were seen with ceftriaxone, cefotaxime, and cefoperazone. The other agents showed a more modest increase, with cephaloridine, cefotetan, and cefoxitin changing only one twofold dilution or less. Similar results were previously found for cefoxitin, cefotaxime, and cefoperazone (2) .
The effect of inoculum size on MIC can be correlated with P-lactamase susceptibility for cefotaxime, cefoperazone, and ceftriaxone, which were susceptible to hydrolysis and inoculum effect, and cefbuperazone, cefotetan, and cefoxitin, which were resistant to hydrolysis and fected by inoculum size increases.
insignificantly ef-DISCUSSION Our results showed cefbuperazone and cefotetan to be equally active against B. fragilis and more active than the other newer cephalosporins and cephamycins evaluated in this study. These two agents were superior in vitro against B. fragilis to cefoperazone, cefotaxime, ceftriaxone, cefmetazole, and ticarcillin, whereas cefoxitin, piperacillin, clindamycin, metronidazole, and moxalactam proved to be more active than cefbuperazone and cefotetan. Imipenem was clearly the most active against B. fragilis of the agents tested, although none of the other newer cephalosporins were much of an improvement over the older agent cefoxitin. These results are similar to those previously reported (2, 3, 10, 15) . Except for imipenem, the activity of all antimicrobial agents tested was clearly poorer against other species in the B. fragilis group and against strains of Bacteroides species, B. melaninogenicus, and Fusobacterium species. The largest difference in activity against B. fragilis as compared with other gram-negative anaerobes was seen among the cephalosporins and moxalactam.
Increasing inoculumn size caused a large increase in MIC of cefotaxime, cefoperazone, and ceftriaxone, an effect previously reported (2) and postulated to be a result of inactivation of the antibiotic by ,-lactamase (11, 16) . Although cefotaxime and sefoperazone were hydrolyzed by B. fragilis ,B-lactamase, other more rapidly hydrolyzed cephalosporins such as cephaloridine did not show an inoculum size effect of similar magnitude. This was previously shown for cefamandole (2). Possibly, our large inoculum, although greater than the standard 105 organisms, was not large enough to bring out a similar effect among other hydrolyzable agents such as cephaloridine, especially in view of the high MIC with B. fragilis at the low inoculum. Alternatively, inoculum size effects may be multifactorial and not entirely determined by 1-lactamase inactivation.
Theoretically, no inoculum effect would be demonstrable in an organism if the antimicrobial agent had great affinity for the critical penicillin-binding protein, even in the face of a noninducible, periplasmic ,-lactamase such as that of B. fragilis. A great affinity for nonessential penicillin-binding protein might be the explanation for the inoculum effect of a compound such as imipenem in B. fragilis (2) , as imipenem is totally resistant to degradation by the ,-lactamase of these organisms. Exceptional outer cell wall permeability for a compound such as cephaloridine might counter the activity of the noninducible periplasmic P-lactamase of B. fragilis, thereby eliminating an inoculum effect. These properties of anaerobic bacteria have just begun to be investigated, and VOL. 27, 1985 on September 27, 2017 by guest http://aac.asm.org/ Downloaded from ANTIMICROB. AGENTS CHEMOTHER.
already differences in affinity of the newer cephalosporins for penicillin-binding proteins of B. fragilis has been reported (1), but there is not yet enough information to explain the phenomena reported here.
Our P-lactamase studies showed that resistance of B.
fragilis to the newer agents is often related to the ,-lactamase activity against the compounds. This is similar to results obtained by others for cephalosporins (4, 5, 11, 12, 16) . The level of resistance to the hydrolyzable cephalosporins correlated moderately well with the rate of hydrolysis of each test strain. In some strains, resistance to a compound is not correlated with hydrolytic activity (Table 3; isolate T130 with cefotetan and isolate T59 with cefoperazone). This may reflect the limnits of sensitivity of the alkalimetric titration method, or, as stated above, other factors such as decreased permeability or decreased affinity for binding proteins may be responsible for the observed in vitro resistance. These factors may be important in producing the results seen with the penicillins also.
Few data have been available regarding the stability of cefbuperazone to B. fragilis P-lactamase. Our results show cefbuperazone to be resistant to P-lactamase derived from eight well-characterized strains, even though some of these strains produce a large amount of P-lactamase. These same organisms were able to hydrolyze other ,-lactam agents used in this study except for cefotetan and cefoxitin. Cefbuperazone, cefotetan, and cefoxitin are cephamycins with a 7a-inethoxy substituent which seems important in Bacteroides P-lactamase resistance (4, 8) .
With respect to the intensity of activity and resistance to hydrolysis, other agents, such as imipenem, moxalactam, and cefoxitin, would appear to have more promise for treatment of infections due to B. fragilis than cefbuperazone and cefotetan.
